Science Explorer Back to mapMap

Most cited papers from Swedish Orphan Biovitrum (Sweden)

What are the most cited papers from Swedish Orphan Biovitrum (Sweden)?

The most cited paper from Swedish Orphan Biovitrum (Sweden) is "Patient reported outcome measures in practice" (Eugene C. Nelson, Elena Eftimovska, Cristin Lind et al., 2015), with 786 citations. Next come "Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells" (497) and "In vitro models for the blood–brain barrier" (399).

Showing 50 of 60 papers. Every paper with more than 108 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Patient reported outcome measures in practice Eugene C. Nelson, Elena Eftimovska, Cristin Lind et al. · BMJ Open access 10 Feb 2015 786
2 Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells Cecil C. Czerkinsky, Gudrun Andersson, Hans-Peter T. Ekre et al. · Journal of Immunological Methods May 1988 497
3 In vitro models for the blood–brain barrier Per Garberg, Marguerite Ball, Natalia Borg et al. · Toxicology in Vitro 27 Aug 2004 399
4 LEKTI Fragments Specifically Inhibit KLK5, KLK7, and KLK14 and Control Desquamation through a pH-dependent Interaction Céline Deraison, Chrystelle Bonnart, Frédéric Lopez et al. · Molecular Biology of the Cell Open access 28 Jun 2007 326
5 Regulation by Growth Hormone of Number of Chondrocytes Containing IGF-I in Rat Growth Plate Anders Nilsson, Jörgen Isgaard, Anders H. Lindahl et al. · Science Aug 1986 319
6 Crystal structure of the heterodimeric complex of LXRα and RXRβ ligand‐binding domains in a fully agonistic conformation Stefan Svensson, Tove Östberg, Micael Jacobsson et al. · The EMBO Journal Open access 11 Sep 2003 283
7 Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve Martin Kanje, Anna Skottner, Jacob Sjo ̈berg et al. · Brain Research May 1989 280
8 Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains Pēteris Alberts, Cecilia Nilsson, Göran Selén et al. · Endocrinology 5 Aug 2003 263
9 Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice Pēteris Alberts, Linda I. Engblom, N. Edling et al. · Diabetologia Open access Nov 2002 259
10 Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle Lubna Al‐Khalili, Karim Bouzakri, Stephan Glund et al. · Molecular Endocrinology Open access 31 Aug 2006 249
11 Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. Marianne Quiding, Inger Nordström, Anders F. Kilander et al. · Journal of Clinical Investigation Open access Jul 1991 230
12 Evidence indicating trophic importance of IGF‐1 in regenerating peripheral nerves Hans‐Arne Hansson, Lars Bertil Dahlin, Nils Danielsen et al. · Acta Physiologica Scandinavica Apr 1986 222
13 Clinical Evaluation of Efficacy and Safety of a New Method for Chemo–Mechanical Removal of Caries Dan Ericson, Mikael Zimmerman, H. Raber et al. · Caries Research 1999 208
14 Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety Josep Malvehy, Axel Hauschild, Clara N. Curiel‐Lewandrowski et al. · British Journal of Dermatology Open access 19 May 2014 208
15 Hadamard NMR spectroscopy Ēriks Kupče, Toshiaki Nishida, Ray Freeman · Progress in Nuclear Magnetic Resonance Spectroscopy Aug 2003 205
16 A Unique Role of Monocyte Chemoattractant Protein 1 among Chemokines in Adipose Tissue of Obese Subjects Ingrid Dahlman, Maria Kaaman, Tommy Olsson et al. · The Journal of Clinical Endocrinology & Metabolism Oct 2005 204
17 Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A Annette von Drygalski, Pratima Chowdary, Roshni Kulkarni et al. · New England Journal of Medicine Open access 25 Jan 2023 202
18 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice Xiaomin Song, Maj Fiedler, Dana Galuska et al. · Diabetologia Open access 2002 186
19 Calculation of the isoelectric points of polypeptides from the amino acid composition Bo Skoog, Anders Wichman · TrAC Trends in Analytical Chemistry Apr 1986 186
20 Downregulation of Electron Transport Chain Genes in Visceral Adipose Tissue in Type 2 Diabetes Independent of Obesity and Possibly Involving Tumor Necrosis Factor-α Ingrid Dahlman, Margaretha Forsgren, Annelie Sjögren et al. · Diabetes 26 May 2006 183
21 DMSO-Related Effects in Protein Characterization Agneta Tjernberg, Natalia Markova, William James Griffiths et al. · SLAS DISCOVERY Open access 20 Feb 2006 178
22 Immunohistochemical localization of insulin-like growth factor I in the adult rat Hans‐Arne Hansson, Anders Nilsson, Jörgen Isgaard et al. · Histochemistry and Cell Biology 1988 176
23 Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients Amy D. Shapiro, Margaret V. Ragni, Leonard A. Valentino et al. · Blood Open access 23 Nov 2011 173
24 CD36 Mediates the Cardiovascular Action of Growth Hormone-Releasing Peptides in the Heart Veronique Bodart, Maria Febbraio, Annie Demers et al. · Circulation Research 3 May 2002 172
25 Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments? Wills Hughes-Wilson, Ana Luiza do Rosário Palma, Ad Schuurman et al. · Orphanet Journal of Rare Diseases Open access 2012 170
26 Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbits E. Holmer, Christer Mattsson, Solveig Nilsson · Thrombosis Research Mar 1982 164
27 CD2 Immunobiology Christian Binder, Filip Cvetkovski, Felix Sellberg et al. · Frontiers in Immunology Open access 9 Jun 2020 163
28 Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment Lakshminarayan R Ranganath et al. · Annals of the Rheumatic Diseases Open access 5 Dec 2014 160
29 Satellite cells express the trophic factor IGF‐I in regenerating skeletal muscle Eva Jennische, Anna Skottner, Hans‐Arne Hansson · Acta Physiologica Scandinavica 1987 160
30 Limiting factors in Escherichia coli fed‐batch production of recombinant proteins Anna Maria Sandén, Ingela Prytz, Ioannis Tubulekas et al. · Biotechnology and Bioengineering 22 Nov 2002 158
31 Asymmetric Hydrogenation of Trisubstituted Olefins with Iridium−Phosphine Thiazole Complexes: A Further Investigation of the Ligand Structure Christian Hedberg, Klas Källström, Peter Brandt et al. · Journal of the American Chemical Society 11 Feb 2006 158
32 New Mechanistic Insights into the Iridium–Phosphanooxazoline‐Catalyzed Hydrogenation of Unfunctionalized Olefins: A DFT and Kinetic Study Peter Brandt, Christian Hedberg, Pher G. Andersson · Chemistry - A European Journal 30 Dec 2002 157
33 Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression Trisha M Suppes, Catherine J Datto, Margaret C. Minkwitz et al. · Journal of Affective Disorders 9 Nov 2009 156
34 Genome-based Identification and Analysis of Collagen-related Structural Motifs in Bacterial and Viral Proteins Magnus Rasmussen, Micael Jacobsson, Lars Björck · Journal of Biological Chemistry Open access Aug 2003 154
35 Rationally Designed Ligands for Asymmetric Iridium-Catalyzed Hydrogenation of Olefins Klas Källström, Christian Hedberg, Peter Brandt et al. · Journal of the American Chemical Society 13 Oct 2004 150
36 Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis David Bergqvist, Ulla Stina Burmark, Jan Frisell et al. · British journal of surgery Mar 1986 144
37 Mechanistic Insights into the Phosphine-Free RuCp*-Diamine-Catalyzed Hydrogenation of Aryl Ketones: Experimental and Theoretical Evidence for an Alcohol-Mediated Dihydrogen Activation Christian Hedberg, Klas Källström, Per I. Arvidsson et al. · Journal of the American Chemical Society 8 Oct 2005 144
38 Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations Christina Kaiser, Ann Knight, Dan Nordström et al. · Rheumatology International Open access 31 Aug 2011 142
39 Safety assessment of astaxanthin-rich microalgae biomass: Acute and subchronic toxicity studies in rats John S. Stewart, Åke Lignell, Annette Frost Pettersson et al. · Food and Chemical Toxicology 11 Jun 2008 139
40 Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma. Lennart Andersson, N Forsman, Kongwei Huang et al. · Proceedings of the National Academy of Sciences Open access May 1986 138
41 Low molecular weight heparin given the evening before surgery compared with conventional low-dose heparin in prevention of thrombosis David Bergqvist, Thomas Mätzsch, Ulla Stina Burmark et al. · British journal of surgery Sep 1988 134
42 CTA1-M2e-DD: A novel mucosal adjuvant targeted influenza vaccine Dubravka Grdic Eliasson, Karim El Bakkouri, Karin Schön et al. · Vaccine 11 Jan 2008 134
43 Rheumatoid Arthritis: The Role of Reactive Oxygen Species in Disease Development and Therapeutic Strategies Kyra A. Gelderman, Malin Hopkins Hultqvist, Lina M. Olsson et al. · Antioxidants and Redox Signaling 3 Aug 2007 131
44 Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial Lakshminarayan R Ranganath et al. · The Lancet Diabetes & Endocrinology Open access 18 Aug 2020 128
45 Protein names and how to find them Kristofer Franzén, Gunnar Eriksson, Fredrik K. Olsson et al. · International Journal of Medical Informatics Open access Dec 2002 128
46 Origin of Enantioselectivity in the Ru(arene)(amino alcohol)-Catalyzed Transfer Hydrogenation of Ketones Peter Brandt, Peter R. Roth, Pher G. Andersson · The Journal of Organic Chemistry Jul 2004 127
47 Crystal Structure and Biological Implications of a Bacterial Albumin Binding Module in Complex with Human Serum Albumin Sara Lejon, Inga-Maria Frick, Lars Björck et al. · Journal of Biological Chemistry Open access 22 Jul 2004 125
48 Idiosyncratic drug‐induced agranulocytosis: Possible mechanisms and management Daniel Tesfa, Marianne Keisu, Jan E.W. Palmblad · American Journal of Hematology Open access 9 Apr 2009 124
49 Anticoagulant effects of two types of low molecular weight heparin administered subcutaneously David Bergqvist, Ulla K.E. Hedner, Elsy Sjörin et al. · Thrombosis Research Nov 1983 120
50 Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteers Göran Bratt, E. Törnebohm, LARS WIDLUND et al. · Thrombosis Research Jun 1986 119

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.